Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. - Wikidata - wikimedia - TriplyDB

Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment.

Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment.

http://www.wikidata.org/entity/Q34507706

about

Statins for the prevention of dementia Statins, cognition, and dementia—systematic review and methodological commentary Cholesterol, statins, and dementia: what the cardiologist should know Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome.Dietary fat composition and dementia risk Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans Importance of cholesterol in dopamine transporter function.Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.Dyslipidemia and the risk of Alzheimer's disease.Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions.Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.Nonlinear longitudinal trajectories of cholesterol and neuropsychological function.Nutritional determinants of cognitive aging and dementia.Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Cognitive effects of statin medications.Assessing premorbid cognitive ability in adults with type 2 diabetes mellitus--a review with implications for future intervention studies.Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies.Statins and cognitive function: an updated review.Comparison between Complementary Dietary Treatment of Alzheimer Disease in Iranian Traditional Medicine and Modern Medicine Metabolic parameters and cognitive function in a cohort of older diabetic patients.The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive Impairment.Cognitive impairment among elderly individuals in Shanghai suburb, China: association of C-reactive protein and its interactions with other relevant factors.Screening for mild cognitive impairment in patients with cardiovascular risk factors.Developing Cognitive Markers of Alzheimer's Disease for Primary Care: Implications for Behavioral and Global Prevention.Association of midlife lipids with 20-year cognitive change: A cohort study.Long-term statin use and dementia risk in Taiwan.Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years.Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.

P2860

Q24186591-3C2A1F02-7ACC-4DCA-A364-1A88508FA567 Q26852778-4F074A06-3819-472D-8518-E94DF7F634A7 Q28081974-769BAF90-5C45-49BC-9662-339CBE60C485 Q28085282-F0FF2630-1F55-4943-9146-6BEF692468B9 Q28655720-F7C5B31A-EF5D-4949-A36B-F631BBBCF5D4 Q33763342-21E70BCF-4CB3-45A5-8991-C0A434707CB5 Q33770940-744A3CCA-D169-42EF-ABA6-C41F24EF3B84 Q33892591-4B6A8396-AC9C-41B4-BA45-522CBBBA66A9 Q33935512-D117F53C-DE24-4127-8B93-EF7C9E967331 Q35087574-8345BC86-C7AA-4CF7-890B-DB64426E1D1B Q36325378-643ADA8E-EB9E-4C8A-ABCA-5FA84B1B6F66 Q36351416-E5C9C50F-AFA4-4EE5-A157-6DBDDDDD0607 Q36453517-96066566-ABB4-490B-A261-FC35E69E5A89 Q36493774-6E23A366-7010-42D8-9073-953C99605945 Q36587136-E97351DB-4470-4C20-8744-BCC305086DBA Q36807552-5FDFA142-509F-46A8-B5FD-69258675604A Q36946758-E2FA0A3D-ED22-4ECD-BCAE-942299120935 Q37139026-7378EBB6-4B91-403B-BAC3-6B92A2D70458 Q37171311-85D12A3A-8C90-4153-8DD8-907755D5B7E4 Q37589656-F06540D1-93B6-40F9-9E79-6EFC8D895242 Q37598119-DAC035FF-11FF-49DB-8259-DB3057198266 Q37953987-AA652549-F110-4D52-AF31-7A138234E665 Q38066159-D2B5BEB1-A9D6-426A-B424-BE48B0C91832 Q38125769-4C55F601-0718-4A0C-B93B-C3C69422BC51 Q38179262-ACF950B5-791D-4AD9-8F4F-86C8A966EEF3 Q38185988-88CFAEBA-45BB-47A7-81AF-2B9F71612181 Q38255909-59E88FD5-C781-4DCD-9F28-98CDD56ADB00 Q38272551-A4E29870-89B3-4095-B964-52707D3AA1C7 Q38287482-2BD01E73-DDAE-4E65-BEF4-0B1EE289687D Q38331105-6711DFB2-F6B2-45D9-B088-975AC1AF36E2 Q40851038-D4A16CE1-3F5B-473F-8D3F-A9F689BD79C8 Q41002434-E38E247E-7E71-44FF-8BB3-4ED0E7596A9D Q43098045-AA77481B-9D54-4AAC-992E-BE13CC35E960 Q43607524-69622052-0B67-4B75-8AF3-76421BE93044 Q47107758-D21DC776-0868-4AC1-BDA2-5E1DA233D275 Q47391689-4646FA95-D236-44A7-8D59-85F5A32A962D Q50063689-5F8886B5-5C86-4FBE-B007-2BE850207E48 Q50657607-6F206A57-15C6-40E2-9701-ACC6D9CB6348 Q50708978-E5DC2EE0-4548-46CB-8FF6-989AAD95DD2C Q52317633-A6E9356C-1FC8-4134-A41C-B84904A45D41

P2860

Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment.

http://www.wikidata.org/entity/Q34507706

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Statins and serum cholesterol' ...... and mild cognitive impairment.

@ast

Statins and serum cholesterol' ...... and mild cognitive impairment.

@en

Statins and serum cholesterol' ...... and mild cognitive impairment.

@nl

type

label

Statins and serum cholesterol' ...... and mild cognitive impairment.

@ast

Statins and serum cholesterol' ...... and mild cognitive impairment.

@en

Statins and serum cholesterol' ...... and mild cognitive impairment.

@nl

prefLabel

Statins and serum cholesterol' ...... and mild cognitive impairment.

@ast

Statins and serum cholesterol' ...... and mild cognitive impairment.

@en

Statins and serum cholesterol' ...... and mild cognitive impairment.

@nl

P1433

Q34507706-663E4D19-C163-4E1D-8093-25829700D378

P1476

Q34507706-902C5356-3C07-4464-8856-D6B996F3DAB7

P2093

Q34507706-02FAA6E2-F64B-41E3-8E4E-8BDC63F9B5DE

Q34507706-156F945D-D7D9-4A3E-B844-743032F721AE

Q34507706-A1EB715B-EB90-4579-AF8F-915F800E1771

Q34507706-B57D081A-0641-44B8-ADCE-EE39F6EA5ADC

Q34507706-BE11A0DD-427D-41DE-85B5-5D970FFBA410

P2860

Q34507706-0034E0D1-73E2-4E52-A730-FBDA91EB47FF

Q34507706-066994D8-2AC8-422C-B8D4-08C539FC25B9

Q34507706-07B299C9-BC06-41AB-BD95-C1F885BBE2F4

Q34507706-0CF90810-210D-4FEE-9DFB-69A7422D9949

Q34507706-17E09BC0-C76E-427B-9A4D-1F6EF3748C37

Q34507706-2169512C-5A30-487C-901B-94CE90BE25B9

Q34507706-23E2274B-3D31-448B-AD81-A378815A563E

Q34507706-30F515E7-300F-4B84-814E-DB08CF51F95C

Q34507706-35F3F739-95E7-4844-9022-A11C214335C0

Q34507706-43F18D69-ED6D-48E5-96D0-28537A7CB4F5

P304

Q34507706-8F5ACB55-363B-4DC3-9F2A-DAD1D91B1C3D

P31

Q34507706-1172F1CB-3D08-4C5C-938E-9671EF498166

P356

Q34507706-3FD8BD7F-8C9F-45FA-9E13-FBEA11AD0D2B

P433

Q34507706-30825155-D1B3-4ED7-8961-F156897ADF2A

P478

Q34507706-E85471F5-3253-46D8-89C3-D97B12D50594

P50

Q34507706-65FE7CA7-1EB3-43B6-9264-223BA77C1FCF

Q34507706-9AD8912C-BD60-45A6-8DA7-2EAB50998B81

P577

Q34507706-C89704E5-55CE-4E2C-83AB-382D2ED7F4B4

P5875

Q34507706-0113D5B3-8342-4FAC-A9C1-74C7F93AAF52

P698

Q34507706-5FFF78F5-31AA-4422-B126-ED6AF4AA0E89

P921

Q34507706-45C6922C-B3DD-4E2E-802D-0959DE12FF55

P932

Q34507706-EDCCBD82-3B09-4897-A770-3CA060F7A85C

P356

JECH.2009.100826

P1433

Journal of Epidemiology and Community Health

P1476

Statins and serum cholesterol' ...... and mild cognitive impairment.

@en

P2093

Hind A Beydoun

http://www.w3.org/2001/XMLSchema#string

Lori L Beason-Held

http://www.w3.org/2001/XMLSchema#string

May A Beydoun

http://www.w3.org/2001/XMLSchema#string

Melissa H Kitner-Triolo

http://www.w3.org/2001/XMLSchema#string

Susan M Resnick

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

The Clinical Dementia Rating (CDR): current version and scoring rules

Mild cognitive impairment as a diagnostic entity

Association of statin use with cognitive decline in elderly African Americans.

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Statins and the risk of dementia.

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis.

P304

949-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JECH.2009.100826

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Alan B. Zonderman

P577

2010-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46273106

http://www.w3.org/2001/XMLSchema#string

P698

20841372

http://www.w3.org/2001/XMLSchema#string

P921

P932

3024452

http://www.w3.org/2001/XMLSchema#string